about
Prevention of poxvirus infection by tetrapyrrolesCytomegalovirus antivirals and development of improved animal modelsInhibition of Poxvirus Gene Expression and Genome Replication by Bisbenzimide DerivativesNew class of orthopoxvirus antiviral drugs that block viral maturation.Identification of polymerase and processivity inhibitors of vaccinia DNA synthesis using a stepwise screening approachComparison of monkeypox viruses pathogenesis in mice by in vivo imagingMousepox in the C57BL/6 strain provides an improved model for evaluating anti-poxvirus therapies.Use of the Aerosol Rabbitpox Virus Model for Evaluation of Anti-Poxvirus Agents.Acyclic nucleoside phosphonates: a key class of antiviral drugs.Capturing the natural diversity of the human antibody response against vaccinia virusAntiviral activity of HPMPC (cidofovir) against orf virus infected lambs.5-(Dimethoxymethyl)-2'-deoxyuridine: a novel gem diether nucleoside with anti-orthopoxvirus activity.Synthesis and antiviral activities of new acyclic and "double-headed" nucleoside analoguesActivities of alkoxyalkyl esters of cidofovir (CDV), cyclic CDV, and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine against orthopoxviruses in cell monolayers and in organotypic culturesToward orthopoxvirus countermeasures: a novel heteromorphic nucleoside of unusual structure.Evaluation of imiquimod for topical treatment of vaccinia virus cutaneous infections in immunosuppressed hairless mice.Treatment of Vaccinia and Cowpox Virus Infections in Mice with CMX001 and ST-246.Gamma interferon and perforin control the strength, but not the hierarchy, of immunodominance of an antiviral CD8+ T cell response.Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.Smallpox: clinical features, prevention, and management.Aerosolized cidofovir is retained in the respiratory tract and protects mice against intranasal cowpox virus challenge.Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone.Vaccinia as a vector for gene delivery.Future directions for the field of oncolytic virotherapy: a perspective on the use of vaccinia virus.Antivirals and antiviral strategies.Potential of acyclic nucleoside phosphonates in the treatment of DNA virus and retrovirus infections.Treatment of verruca vulgaris with topical cidofovir in an immunocompromised patient: a case report and review of the literature.Evaluation of inhaled cidofovir as postexposure prophylactic in an aerosol rabbitpox model.Efficacy of N-methanocarbathymidine in treating mice infected intranasally with the IHD and WR strains of vaccinia virusLow-resolution structure of vaccinia virus DNA replication machineryHuman monkeypox: an emerging zoonotic disease.Coadministration of cidofovir and smallpox vaccine reduced vaccination side effects but interfered with vaccine-elicited immune responses and immunity to monkeypoxSerine peptide phosphoester prodrugs of cyclic cidofovir: synthesis, transport, and antiviral activityIdentification of non-nucleoside DNA synthesis inhibitors of vaccinia virus by high-throughput screening.Inhibition of monkeypox virus replication by RNA interference.Camelpox: epidemiology, diagnosis and control measures.Oncolytic vaccinia virus for the treatment of cancer.The design and development of drugs acting against the smallpox virus.The acyclic nucleoside phosphonates (ANPs): Antonín Holý's legacy.Cidofovir Activity against Poxvirus Infections.
P2860
Q24806638-EB54E4DA-8439-4249-91D5-32016DEC91FEQ27000998-33806EC9-25E9-46A2-95A0-44F2878A098BQ32174436-FDF9598F-AC73-439A-A6BA-2AF6A5FC0F4CQ33208347-8A59CA45-F4AF-470C-A89B-542A9C74609AQ33351233-3E73D6D9-7F29-4E4F-9573-405CEBC8B6EEQ33492317-137B280E-A6B4-4380-904E-2CAC1400A496Q33570349-FEBB7F7C-6EDB-4328-A954-6B7648942ADBQ34196187-1F324503-5E86-49B8-BF25-3A789402A824Q34464655-CDE70F05-F9D1-4011-9068-6EA29F767AA1Q34529713-24CC3F30-5786-4D62-A267-60684B6F10A7Q34571871-2FECCD87-1E14-49BB-A719-B9F9C070F0C1Q34676027-D958659C-13C2-413E-80D2-3C166E66831BQ34698954-C7A16401-287D-402F-B56E-51A06788DF69Q34721564-694338CD-B1BB-42CF-9981-187BC8EBD68EQ34984243-C33BD10F-8B91-40F5-BD93-551610B8776CQ35007525-FC11ED03-ED04-4072-90CB-067759C73B52Q35260533-5C155876-7050-4E24-B970-95809631976BQ35531658-2A51991D-F295-471D-A3E4-B4DD4E2C29B6Q35558801-9F47C1B1-1D21-46EF-95AB-87A49CC43524Q35644860-985F8459-34CF-4100-8ADC-0F34AAF87329Q35685188-39529A11-0A5C-4CB3-BCA2-BF0FDD2B7292Q35738585-68DB095C-A826-4588-882C-97410D84D242Q35790868-22D13441-C2EE-454E-91F8-F83FA1FEBA23Q35842621-F968762B-08DC-4D38-8693-3B4A212ADA9BQ35889586-73A9F044-4A93-4281-8142-65491350AE6FQ35917125-89F5E4B1-78CD-4A0C-97D4-D1297C69D812Q36359399-23E67E77-7036-4338-BF4D-50051ED37AEEQ36422006-6091B42F-D57D-491D-B6ED-E146A95BE936Q36499021-6F473CC2-BFFE-40A7-A4F0-DE4B8442377AQ36559777-E8D36514-28A8-4F11-A189-7E88E9DFF518Q36895707-D3614331-ED6B-4FB3-BF10-9ECD35BFB18EQ37033408-2915DFC9-0A31-455D-B330-7D0637EAB973Q37069884-C58C107D-7B6C-4A58-B4A5-AF83E337A474Q37114693-172254EE-A25A-4C36-898D-7D033D515182Q37422402-1EB01174-DE57-44EA-BF46-F3A6E743F88BQ37800922-713BB034-43D1-48C9-AE37-8EBB462004C7Q37845399-88A833F1-7465-48F9-913B-C3E94D7E02A4Q38089868-328ECAD1-E9F1-4705-A704-10960E4DDC74Q38097391-8DFE97F7-983B-4C98-A30B-D31791C6B5B5Q38614278-10FB35BF-0D6B-44C6-A045-0180F98D9978
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cidofovir in the treatment of poxvirus infections.
@ast
Cidofovir in the treatment of poxvirus infections.
@en
Cidofovir in the treatment of poxvirus infections.
@nl
type
label
Cidofovir in the treatment of poxvirus infections.
@ast
Cidofovir in the treatment of poxvirus infections.
@en
Cidofovir in the treatment of poxvirus infections.
@nl
prefLabel
Cidofovir in the treatment of poxvirus infections.
@ast
Cidofovir in the treatment of poxvirus infections.
@en
Cidofovir in the treatment of poxvirus infections.
@nl
P1433
P1476
Cidofovir in the treatment of poxvirus infections.
@en
P356
10.1016/S0166-3542(02)00008-6
P577
2002-07-01T00:00:00Z